US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avon

5.60

0.0000

Volume:- -

Turnover:- -

Market Cap:2.48B

PE:-48.65

High:5.60

Open:5.60

Low:5.60

Close:5.60

52wk High:5.92

52wk Low:1.59

Shares:443.53M

Float Shares:378.82M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1151

EPS(LYR):-0.0987

ROE:-1.62%

ROA:6.61%

PB:-2.75

PE(LYR):-56.76

Loading ...

Overview Company News Filings

Rhythm Pharmaceuticals to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026

Deutsche Bank Sticks to Its Hold Rating for Avon Technologies (AVON)

Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity

Evolving Luxury and Intelligence: LUXEED Set to Launch Global Media Drive

Barclays Sticks to Their Hold Rating for Avon Technologies (AVON)

Avon Technologies Executives Add Shares Under Employee Incentive Plan

Avon Technologies Lifts FY26 Outlook and Sets Ambitious Growth Strategy

BYD launches updated Yuan Up in China from $11,070 with longer-range options

Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting

Avon Technologies Executives Add Shares Under Employee Incentive Plan

HyTerra Director Boosts Shareholding via Incentive Conversion

Avon Technologies: Buy Rating Reiterated on New US$20.3m ACH GEN II Order and Unchanged $2390 Price Target

Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan

Press Release: Regent to Acquire Avon North America, Reuniting Major Avon Businesses After More than a Decade Apart

LG H&H Unit to Convert KRW286 Billion Avon Loan into Equity

MT Newswires Live

LG H&H Exits Avon in North America Portfolio Restructuring

MT Newswires Live

Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer

Avon Technologies Sets Sterling Value for Interim Dividend Payout

Einride and DAF Partner to Accelerate Scale-up of Autonomous Electric Freight

Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/AVP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVP\",,,,,undefined,":{"symbol":"AVP","market":"US","secType":"STK","nameCN":"Avon","latestPrice":5.6,"timestamp":1578085200000,"preClose":5.6,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":378820896,"shares":443525346,"eps":-0.115112,"marketStatus":"Delisted","change":0,"latestTime":"10-22 10:23:27 EDT","open":5.6,"high":5.6,"low":5.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.115112,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1792699200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-179866800000,"exchange":"NYSE","adjPreClose":5.6,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVP\",,,,,undefined,":{"symbol":"AVP","floatShares":378820896,"roa":"6.61%","roe":"-1.62%","lyrEps":-0.098664,"shares":443525346,"dividePrice":0,"high":5.6,"amplitude":0,"preClose":5.6,"low":5.6,"week52Low":1.59,"pbRate":"-2.75","week52High":5.92,"institutionHeld":0.685,"latestPrice":5.6,"eps":-0.115112,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.115112,"open":5.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-12-27","symbol":"AVP","amount":0.0160442,"name":"雅芳","payableDate":"2019-12-30","currency":"USD","type":"dividend","dateTimestamp":1577422800000},{"date":"2019-10-31","symbol":"AVP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":0.03,"defaultRemindTime":1572508800000,"name":null,"time":"Pre-MKt","dateTimestamp":1572494400000,"actualEps":null},{"date":"2019-08-01","symbol":"AVP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":0.04,"defaultRemindTime":1564646400000,"name":null,"time":"Pre-MKt","dateTimestamp":1564632000000,"actualEps":-0.03},{"market":"US","date":"2019-05-02","symbol":"AVP","fiscalQuarterEnding":"2019/03","expectedEps":-0.01,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1556769600000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2019-02-14","symbol":"AVP","fiscalQuarterEnding":"2018/12","expectedEps":0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1550120400000,"reportTimeType":"pre","actualEps":0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVP\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":null,"value":0.0160442,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2677752676","title":"Rhythm Pharmaceuticals to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2677752676","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677752676?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:00","pubTimestamp":1792584000,"startTime":"0","endTime":"0","summary":"BOSTON, Oct.  21, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ra","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/21/3385449/0/en/rhythm-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-tuesday-november-3-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VUS","BK4201","AVP","EC","DI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675553384","title":"Deutsche Bank  Sticks to Its Hold Rating for Avon Technologies (AVON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2675553384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675553384?lang=en_us&edition=fundamental","pubTime":"2026-10-16 05:55","pubTimestamp":1792101318,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst reiterated a Hold rating on Avon Technologies today and set a price target of p2,480.00. In a report released on October 7, B...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-bank-sticks-to-its-hold-rating-for-avon-technologies-avon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-bank-sticks-to-its-hold-rating-for-avon-technologies-avon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP","DB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675039314","title":"Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2675039314","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675039314?lang=en_us&edition=fundamental","pubTime":"2026-10-14 07:30","pubTimestamp":1791934200,"startTime":"0","endTime":"0","summary":"-- Launch follows MHLW approval of IMCIVREE for acquired hypothalamic obesity and inclusion on Japan's National Health Insurance drug price list -- -- IMCIVREE is the first approved therapy in Japan f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/13/3380291/0/en/rhythm-pharmaceuticals-announces-commercial-launch-of-imcivree-setmelanotide-in-japan-for-patients-with-acquired-hypothalamic-obesity.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4203","BK4225","BK4157","NHI","AVP","EC","BMI","VUS","DI","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674689026","title":"Evolving Luxury and Intelligence: LUXEED Set to Launch Global Media Drive","url":"https://stock-news.laohu8.com/highlight/detail?id=2674689026","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674689026?lang=en_us&edition=fundamental","pubTime":"2026-10-11 00:51","pubTimestamp":1791651060,"startTime":"0","endTime":"0","summary":"WUHU, China, Oct.  10, 2026 (GLOBE NEWSWIRE) -- As the 2026 Chery International User Summit, operated by Chery Group, taking place from October 18 to 24 in Wuhu, China, draws near, LUXEED is set to la","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/10/3378455/0/en/evolving-luxury-and-intelligence-luxeed-set-to-launch-global-media-drive.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","CDC","NOA","AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673298680","title":"Barclays Sticks to Their Hold Rating for Avon Technologies (AVON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673298680","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673298680?lang=en_us&edition=fundamental","pubTime":"2026-10-08 14:45","pubTimestamp":1791441930,"startTime":"0","endTime":"0","summary":"Barclays analyst Milene Kerner maintained a Hold rating on Avon Technologies today and set a price target of £24.50. According to TipRanks, Kerner ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-their-hold-rating-for-avon-technologies-avon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-their-hold-rating-for-avon-technologies-avon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673091233","title":"Avon Technologies Executives Add Shares Under Employee Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2673091233","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673091233?lang=en_us&edition=fundamental","pubTime":"2026-10-07 17:32","pubTimestamp":1791365561,"startTime":"0","endTime":"0","summary":"An announcement from Avon Technologies ( ($GB:AVON) ) is now available. Avon Technologies plc has disclosed small share purchases by its chief exec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-executives-add-shares-under-employee-incentive-plan-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-executives-add-shares-under-employee-incentive-plan-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673987450","title":"Avon Technologies Lifts FY26 Outlook and Sets Ambitious Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2673987450","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673987450?lang=en_us&edition=fundamental","pubTime":"2026-10-07 14:16","pubTimestamp":1791353795,"startTime":"0","endTime":"0","summary":"Avon Technologies ( ($GB:AVON) ) has provided an update. Avon Technologies has outlined the next phase of its strategy, branded “Improve. Grow. Com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-lifts-fy26-outlook-and-sets-ambitious-growth-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-lifts-fy26-outlook-and-sets-ambitious-growth-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668582209","title":"BYD launches updated Yuan Up in China from $11,070 with longer-range options","url":"https://stock-news.laohu8.com/highlight/detail?id=2668582209","media":"CnEVPost","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668582209?lang=en_us&edition=fundamental","pubTime":"2026-09-17 11:11","pubTimestamp":1789614693,"startTime":"0","endTime":"0","summary":"The 2027 Yuan Up increases maximum range from 401 km to 501 km and lowers the starting price for 401-km variants.","market":"nz","thumbnail":"data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20480%20270'%3E%3C/svg%3E","type":0,"news_type":0,"thumbnails":["data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20480%20270'%3E%3C/svg%3E"],"rights":{"source":"cnevpost_highlight","url":"https://cnevpost.com/2026/09/17/byd-launches-updated-yuan-up-china/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cnevpost.com/2026/09/17/byd-launches-updated-yuan-up-china/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"cnevpost_highlight","symbols":["FCA","NEV","AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530593","title":"Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530593","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530593?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:00","pubTimestamp":1789041600,"startTime":"0","endTime":"0","summary":"-- Real-world data showed reductions in BMI with up to 18 months of setmelanotide therapy in 30 paediatric patients with acquired hypothalamic obesity (HO) in France – -- Phase 3 analyses demonstrated","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359459/0/en/rhythm-pharmaceuticals-announces-new-data-presentations-at-the-european-society-for-paediatric-endocrinology-meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPV","AVP","EC","VUS","BK4166","BK4201","VAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665792523","title":"Avon Technologies Executives Add Shares Under Employee Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2665792523","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665792523?lang=en_us&edition=fundamental","pubTime":"2026-09-08 23:12","pubTimestamp":1788880342,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Avon Technologies ( ($GB:AVON) ). Avon Technologies plc disclosed that its chief executive officer, Jos Sclater...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-executives-add-shares-under-employee-incentive-plan-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-executives-add-shares-under-employee-incentive-plan-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665313588","title":"HyTerra Director Boosts Shareholding via Incentive Conversion","url":"https://stock-news.laohu8.com/highlight/detail?id=2665313588","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665313588?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:18","pubTimestamp":1788772693,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Triple Energy Limited ( ($AU:HYT) ). HyTerra Limited has disclosed a change in the interests of director Avon M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hyterra-director-boosts-shareholding-via-incentive-conversion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hyterra-director-boosts-shareholding-via-incentive-conversion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664892883","title":"Avon Technologies: Buy Rating Reiterated on New US$20.3m ACH GEN II Order and Unchanged $2390 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2664892883","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664892883?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:55","pubTimestamp":1788335720,"startTime":"0","endTime":"0","summary":"Andrew Douglas, an analyst from Jefferies, reiterated the Buy rating on Avon Technologies. The associated price target remains the same with p2,390...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/avon-technologies-buy-rating-reiterated-on-new-us20-3m-ach-gen-ii-order-and-unchanged-2390-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/avon-technologies-buy-rating-reiterated-on-new-us20-3m-ach-gen-ii-order-and-unchanged-2390-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP","ACH","GEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661627957","title":"Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2661627957","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661627957?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":"-- Approximately 5,000 to 8,000 patients estimated to be living with acquired HO in Japan -- -- Commercial launch in Japan expected by end of 2026, pending final pricing determination --  BOSTON, Aug.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349657/0/en/rhythm-pharmaceuticals-announces-mhlw-approval-of-imcivree-setmelanotide-for-patients-with-acquired-hypothalamic-obesity-ho-in-japan.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP","VUS","BMI","BK4201","EC","BK4157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276547","title":"Press Release: Regent to Acquire Avon North America, Reuniting Major Avon Businesses After More than a Decade Apart","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276547","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276547?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":"The acquisition brings Avon North America and Avon International back together under common ownership for the first time since 2016, while enabling LG H&H to further focus on its core global   K-beaut","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Regent to Acquire Avon North America, Reuniting Major Avon Businesses After More than a Decade Apart","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661715273","title":"LG H&H Unit to Convert KRW286 Billion Avon Loan into Equity","url":"https://stock-news.laohu8.com/highlight/detail?id=2661715273","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661715273?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:18","pubTimestamp":1787570282,"startTime":"0","endTime":"0","summary":"LG H&H  said its unit LG H&H USA will convert a 286.3 billion won loan extended to The Avon Company into equity, according to a Monday filing with the Korean Exchange.The South Korean consumer goods company said that the conversion will improve the financial structure of the company, with the debt-to-equity swap expected on Sept. 1.As part of the transaction, no separate cash will be paid, and LG H&H USA will maintain 100% ownership of The Avon Company.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVP","EQR","BK4585","BK4588","REZ","BK4215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661426278","title":"LG H&H Exits Avon in North America Portfolio Restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=2661426278","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661426278?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:44","pubTimestamp":1787568299,"startTime":"0","endTime":"0","summary":"LG H&H's  U.S. subsidiary has agreed to sell its entire 100% stake in The Avon Company to Stratford Worldwide for 8.36 billion won as part of a strategic restructuring of its North American business portfolio.The disposal, scheduled to close on Sept. 1, was approved by LG H&H USA's board on Aug. 23, also includes the transfer of all 2,008 shares of The Avon Company Canada to Stratford for a nominal $1.The sale will see LG H&H USA reduce its stake in Avon from 60 million shares to zero, representing a disposal ratio of about 0.1% of LG H&H's total consolidated assets.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660848797","title":"Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660848797","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660848797?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:00","pubTimestamp":1786968000,"startTime":"0","endTime":"0","summary":"BOSTON, Aug.  17, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/17/3346041/0/en/rhythm-pharmaceuticals-announces-appointment-of-manher-aj-joshi-as-chief-medical-officer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052756011.USD","LU0128525929.USD","IE00BFXG0V08.USD","LU0889566641.SGD","NKE","BK4566","BK4558","LU1267930813.SGD","LU0708994859.HKD","LU1267930227.SGD","LU0823411888.USD","AVP","LU1267930573.SGD","BK4533","LU0310800379.SGD","LU0792757196.USD","BK4534","LU0786609619.USD","VUS","LU0128525689.USD","EC","BK4581","IE00BYQQ9H92.USD","STYL","BK4585","LU2098885051.SGD","BK4588","LU1303367103.USD","BK4201","BK4146","LU0310800965.SGD","LU0029864427.USD","BK4561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659213729","title":"Avon Technologies Sets Sterling Value for Interim Dividend Payout","url":"https://stock-news.laohu8.com/highlight/detail?id=2659213729","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659213729?lang=en_us&edition=fundamental","pubTime":"2026-08-13 16:55","pubTimestamp":1786611357,"startTime":"0","endTime":"0","summary":"Avon Technologies ( ($GB:AVON) ) has shared an update. Avon Technologies plc has confirmed the sterling value of its previously announced interim d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-sets-sterling-value-for-interim-dividend-payout?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-sets-sterling-value-for-interim-dividend-payout?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658792219","title":"Einride and DAF Partner to Accelerate Scale-up of Autonomous Electric Freight","url":"https://stock-news.laohu8.com/highlight/detail?id=2658792219","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658792219?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:30","pubTimestamp":1786530600,"startTime":"0","endTime":"0","summary":"An important step towards large-scale commercialization of SAE Level 4 trucks","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343474/0/en/einride-and-daf-partner-to-accelerate-scale-up-of-autonomous-electric-freight.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP","AAQC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658902819","title":"Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment","url":"https://stock-news.laohu8.com/highlight/detail?id=2658902819","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658902819?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:00","pubTimestamp":1786449600,"startTime":"0","endTime":"0","summary":"-- MHRA grants authorization for patients 4 years of age and above with acquired hypothalamic obesity due to hypothalamic injury or impairment --BOSTON, Aug.  11, 2026  (GLOBE NEWSWIRE) -- Rhythm Phar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/11/3342640/0/en/rhythm-pharmaceuticals-announces-imcivree-setmelanotide-receives-expanded-marketing-authorization-in-the-united-kingdom-for-treatment-of-obesity-and-control-of-hunger-in-patients-w.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP","UBCP","BK4211","BMI","BK4201","BK4157","VUS","EC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}]}}